# Visterra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/visterra

- Industry: Pharmaceuticals
- Headquarters: Waltham, US
- Website: www.visterrainc.com
- Total disclosed funding: $133M
- Latest round: Series C (Oct 5, 2017)
- Investors on record: 13

## About

Founded in 2007 and based in Massachusetts, US, Visterra, Inc. (formerly known as Parasol Therapeutics, Inc.) operates as a biopharmaceutical company that develops antibody-based biological medicine for the treatment of infectious diseases.

## Funding rounds

- Series C, Oct 5, 2017, $24M — Flagship Pioneering, Polaris Partners, Alexandria Venture Investments, Cycad Group, CTI Life Sciences, Merck Global Health Innovation Fund, Omega Funds, Bill & Melinda Gates Foundation, Allegheny Financial Group, Vertex Ventures HC, Serum Institute of India Pvt. Ltd.
- Series C, Jun 1, 2016, $23M — CTI Life Sciences
- Series B, Oct 2, 2014, $30M — Flagship Pioneering, Temasek Holdings, Polaris Partners, Alexandria Venture Investments, Cycad Group, Merck Global Health Innovation Fund, Omega Funds, Vertex Ventures HC
- Series B, May 15, 2014, $3.6M — Polaris Partners
- Series A, Dec 2, 2013, $8.1M — Flagship Pioneering, Polaris Partners, Lux Capital, Omega Funds, Bill & Melinda Gates Foundation
- Series A, Nov 5, 2012, $13M — Flagship Pioneering, Polaris Partners, Lux Capital, Omega Funds, Bill & Melinda Gates Foundation
- Series A, Nov 2, 2012, $13M — Flagship Pioneering, Polaris Partners
- Series A, May 14, 2012, $13M — Flagship Pioneering, Polaris Partners, Lux Capital
- Seed, Nov 30, 2009, $3.2M — Flagship Pioneering, Polaris Partners, Lux Capital
- Seed, Jan 28, 2008, $2M — Polaris Partners

## Investors

- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Seed, Series A, Series B, Series C
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Seed, Series A, Series B, Series C
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed, Series A
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series A, Series B, Series C
- Bill & Melinda Gates Foundation — Series A, Series C
- Temasek Holdings — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B, Series C
- Cycad Group (https://capitalatlas.ai/funds/cycad-group) — Series B, Series C
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series B, Series C
- Vertex Ventures HC (https://capitalatlas.ai/funds/vertex-ventures-hc) — Series B, Series C
- CTI Life Sciences (https://capitalatlas.ai/funds/cti-life-sciences) — Series C
- Allegheny Financial Group (https://capitalatlas.ai/funds/allegheny-financial-group) — Series C
- Serum Institute of India Pvt. Ltd. — Series C